Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor
CA 2310069 A1 · Owner: Hoover, Dennis Jay · Inventors: Mylari, Banavara Lakshman; Treadway, Judith Lee; Hoover, Dennis Jay
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pharmaceutical combination compositions and methods including aldose reductase inhibitors and glycogen phosphorylase inhibitors. The compositions and methods are useful for the treatment insulin resistant conditions such as diabetes and in reducing tissue damage due to ischemia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 2, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 2, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 2, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.